Relationship Between Renal Function and Pharmacokinetics of Apixaban and Clinical Outcome of Apixaban in Thai Non-valvular Atrial Fibrillation Patients
NCT04684732 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 241
Last updated 2021-01-29
Summary
The purpose of this study is to assess pharmacokinetics and pharmacodynamics of Apixaban and clinical outcome of Apixaban in Thai patients with nonvalvular atrial fibrillation with varying degree of creatinine clearance
Conditions
Sponsors & Collaborators
-
Thammasat University
collaborator OTHER -
Chulalongkorn University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-14
- Primary Completion
- 2021-05-31
- Completion
- 2021-07-31
Countries
- Thailand
Study Locations
More Related Trials
-
Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice
NCT03847181 ·Status: COMPLETED
-
Apixaban in Atrial Fibrillation Registry
NCT02563639 ·Status: COMPLETED
-
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
NCT04432220 ·Status: RECRUITING ·Phase: PHASE4
-
LAAO Versus NOAC in Patients with AF and PCI
NCT05353140 ·Status: RECRUITING ·Phase: NA
-
Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
NCT04298723 ·Status: RECRUITING ·Phase: NA
-
A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan
NCT05027061 ·Status: COMPLETED
-
COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2
NCT06396299 ·Status: RECRUITING
-
Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation
NCT06869083 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study
NCT04001205 ·Status: ACTIVE_NOT_RECRUITING
-
Low-dose NOAC Versus GDMT After LAAO
NCT05960721 ·Status: RECRUITING ·Phase: NA
-
Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation
NCT03108872 ·Status: UNKNOWN
-
Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients
NCT04062071 ·Status: UNKNOWN
-
Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2
NCT02488421 ·Status: COMPLETED
-
Atrial Fibrillation Research Database
NCT03760874 ·Status: UNKNOWN
-
Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden
NCT03311139 ·Status: COMPLETED
-
A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
NCT00938730 ·Status: COMPLETED ·Phase: PHASE2
-
Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)
NCT06874894 ·Status: ENROLLING_BY_INVITATION
-
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
NCT02608099 ·Status: COMPLETED ·Phase: PHASE4
-
Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation
NCT03073850 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Left Atrial Appendage Velocity on Left Atrial Structure and Function After Radiofrequency Ablation Combined With Left Atrial Appendage Occlusion
NCT04693871 ·Status: COMPLETED
-
A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity
NCT03893591 ·Status: COMPLETED
-
Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US
NCT02674594 ·Status: COMPLETED
-
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
NCT06949319 ·Status: RECRUITING
-
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
NCT03987711 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Monitoring of Patients Having Pulmonary Vein Ablation
NCT00590668 ·Status: COMPLETED